OAB-056: Early, deep, and durable responses, and low rates of cytokine release syndrome with REGN5458, a BCMAxCD3 bispecific antibody, in a Phase 1/2 study in patients with relapsed/refractory multiple myeloma
Title:
OAB-056: Early, deep, and durable responses, and low rates of cytokine release syndrome with REGN5458, a BCMAxCD3 bispecific antibody, in a Phase 1/2 study in patients with relapsed/refractory multiple myeloma
Author:
Zonder, Jeffrey Richter, Joshua Bumma, Naresh Brayer, Jason Hoffman, James E. Bensinger, William I. Wu, Ka Lung Xu, Linzhi Chokshi, Dhruti Boyapati, Anita Cronier, Damien Houvras, Yariv Lorenc, Karen Rodriguez Kroog, Glenn S. Dhodapkar, Madhav V. Lentzsch, Suzanne Cooper, Dennis Jagannath, Sundar